MALIGNANT PERITONEAL MESOTHELIOMA
Clinical trials for MALIGNANT PERITONEAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERITONEAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for MALIGNANT PERITONEAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown tumor models could personalize mesothelioma care
Disease control Recruiting nowThis study tests a new way to choose cancer treatments for people with peritoneal mesothelioma. After surgery, doctors will grow a model of the patient's tumor in the lab and test different drugs on it to find the best match. The goal is to see if this personalized approach helps…
Matched conditions: MALIGNANT PERITONEAL MESOTHELIOMA
Phase: NA • Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Immune cells engineered to fight mesothelioma enter human testing
Disease control Recruiting nowThis early-phase trial tests a new treatment for people with mesothelioma that cannot be removed by surgery or has come back after standard therapy. The treatment uses donor immune cells (natural killer cells) that are engineered in a lab to recognize and attack two proteins foun…
Matched conditions: MALIGNANT PERITONEAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC